Losers at NASDAQ: Prana Biotechnology Limited (NASDAQ:PRAN), Microvision (NASDAQ:MVIS), Body Central (NASDAQ:BODY), Marchex (NASDAQ:MCHX)


Investors in Prana Biotechnology Ltd (NASDAQ:PRAN) saw new options begin trading this week, for the November 22nd expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. On last trading day Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) ended up -5.81%lower to close at $9.89 while trading in the range of $8.80 – $10.36. Its return on assets (ROA) is -113.40% while return on investment (ROI) is -53.00%.Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) monthly performance is -11.93%.

Microvision Inc. (NASDAQ:MVIS) was a big mover last session with its shares rising just over 18% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.95 to $2.33 in the past one-month time frame. Microvision, Inc. (NASDAQ:MVIS) in last trading activity ended up at $1.85 with day range of $1.81 – $2.04. Company weekly performance is -6.09% while its quarterly performance stands at 66.67%.Microvision, Inc. (NASDAQ:MVIS) is -46.99% away from its 52 week high.

Body Central Corp (NASDAQ:BODY) stock was witness to one of its worst performances at the stock market on 26th March, when its market valuation evaporate by close to 35 percent during the day’s trading. The investor stampede out of the stock was triggered by forgettable results that the company announced for its fourth quarter operations after markets closed on 25th March. Body Central Corp (NASDAQ:BODY) belongs to Services sector with market capitalization of 14.89 million and has 1.00% insider ownership. In last trading activity company’s stock closed at $0.910 while opening price was $1.05.

Marchex, Inc. (NASDAQ:MCHX) on Mar. 26 announced the pricing of its underwritten public offering of 5,714,000 shares of Marchex’s Class B common stock at a price to the public of $10.50 per share.
On Thursday shares of Marchex, Inc. (NASDAQ:MCHX) opened at $10.24 and closed at $10.41. This year Company’s Earnings per Share (EPS) growth is -1.01 and next year’s estimated EPS growth is 25.81%. Analysts mean target price for Marchex, Inc. (NASDAQ:MCHX) is $15.00.

Get Free Updates and Stock Alerts!

*We only send one email per week

Get Winning Stock Alerts!

Our track record speaks for itself! Our last 7 alerts have delivered combined gains in excess of 300% and there are no signs of slowing down. Join UltimateStockAlerts.com now before you miss out on our next big runner!

We will never sell or share your information.